Basic Info
  • Grade: Injection & Tablets

    Factory Location: Building C5, No.9 Weidi Road, Xianlin Street, Qixia District, Nanjing City, Jiangsu Province, China

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: yes

    Payment Terms: L/C

    Semaglutide is a long-acting GLP-1 receptor agonist (GLP-1RA) 
    administered once a week. By inhibiting the DPP-4 enzyme, it 
    extends the half-life of GLP-1 receptors, enhances insulin 
    secretion in a glucose-dependent manner, suppresses glucagon 
    secretion, and slows gastric emptying, ultimately reducing blood 
    sugar levels. Additionally, Semaglutide has effects on weight 
    loss, glycemic control, and cardiovascular benefits. It also 
    inhibits appetite, reducing food intake to achieve weight 
    reduction

Send your message to this supplier
  • From:
  • To:
    Nanjing Hanxin Pharmaceutical Technology Co.,Ltd
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service